| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 121,8 k € | +295.7% | -62,2 k € | |
| EBITDA | 121,5 k € | +295.0% | -62,3 k € | |
| Operating profit | 121,5 k € | +295.0% | -62,3 k € | |
| Profit/loss | 125,2 k € | +299.9% | -62,6 k € | |
| Equity | 153,0 k € | +451.3% | 27,7 k € | |
| Total assets | 345,4 k € | +35.1% | 255,7 k € | |
| Cash | 82,5 k € | +27.0% | 65,0 k € | |
| Debts | 87,4 k € | -61.7% | 228,0 k € | |
International non-profit organization · Lier · incorporated on 01/08/2012
International non-profit organization profitable and well capitalised. Cash position rising (+27.0%).
Solid counterparty for a standard engagement.
International Society for the study and exchange of evidence from clinical research and medical experience is a International non-profit organization incorporated in 2012. Its main activity is: Other human health activities. Its registered office is in Lier.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette